Loading data for DRTSW — first visit, this takes a few seconds.
Alpha Tau Medical Ltd. (DRTSW)
NasdaqCM: DRTSW
· Real-Time Price · USD
4.24
+0.39 (10.13%)
At close: Aug 28, 2026, 7:57 PM
The price, the headline numbers and the latest news, in one place.
Alpha Tau Medical Ltd. (DRTSW) Stock Price, Analysis & Data
10.13% (1D)
No data available
| Bid | n/a |
| Market Cap | n/a |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -92.57M |
| 1.19 | |
| n/a | |
| n/a | |
| n/a | |
| P/B (ttm) | 7.95 |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | n/a |
| Volume | 112,854 |
| Avg. Volume (20D) | |
| Open | 0.33 |
| Previous Close | 3.85 |
| Day's Range | 3.80 - 4.25 |
| 52-Week Range | 3.80 - 4.25 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About DRTSW
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The ...
IPO Date Jul 17, 2026
Employees 121
Stock Exchange NasdaqCM
Ticker Symbol DRTSW
Website https://www.alphatau.com
Financial Performance
In 2025, Alpha Tau Medical's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -42.63M, an increase of 34.26%.
Financial Statements
Page 1 of 2